Who We Are
Throughout her career, Dr. Cottini has worked to understand the impact of multiple myeloma on patients – from renal failures to fractures to cord compression and more – and how identifying strategies to treat patients can improve outcomes and reduce acute events caused by disease progression.
She brings her extensive background and training to the OSUCCC – James, and along with her team of research specialists and subspecialists, works consistently – encouraging novel ideas and approaches – to customize and personalize targeted treatment regimens that are tailored specifically to each patient.
Principal Investigator:
Other Team Members:
- Allen Robinette, BS, Research Assistant
- Joshua Galloway, Undergraduate Student
- Aya Ismael, Undergraduate Student
- Vincent Manning, Undergraduate Student
- Ruchi Kudalkar, Undergraduate Student
Collaboration with Other Ohio State Labs and Research Teams
The Cottini Lab regularly collaborates with the OSUCCC – James Translational Therapeutics Program, where nationally and internationally recognized cancer researchers translate advances in solid tumor molecular biology and promising preclinical studies into innovative clinical trials to improve the state of the art in the diagnosis and treatment of solid tumors.
Additionally, the lab collaborates with various OSUCCC – James scientists from other research teams who share unique perspectives and novel techniques, and who offer new approaches to understanding and analyzing multiple myeloma. Collaborative researchers include:
- Don Benson, MD, PhD
- Lisa Blackburn, MS, APRN-CNS
- Emanuele Cocucci, MD, PhD
- Blake Peterson, PhD
For more information on the Cottini Lab team, collaborations, opportunities and lab-specific inquiries, please contact francesca.cottini@osumc.edu.